COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
- PMID: 35454019
- PMCID: PMC9031774
- DOI: 10.3390/diagnostics12040971
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
Abstract
Seroprevalence studies are essential to get an accurate estimate of the actual SARS-CoV-2 diffusion within populations. We report on the findings of the first serosurvey conducted in Tunis prior to the implementation of mass vaccination and analyzed factors associated with seropositivity. A household cross sectional survey was conducted (March-April 2021) in Tunis, spanning the end of the second wave and the beginning of the third wave of COVID-19. SARS-CoV-2 specific immunoglobulin G (IgG) antibodies to the spike (S-RBD) or the nucleocapsid (N) proteins were detected by in-house ELISA tests. The survey included 1676 individuals from 431 households. The mean age and sex ratio were 43.3 ± 20.9 years and 0.6, respectively. The weighted seroprevalence of anti-N and/or anti-S-RBD IgG antibodies was equal to 38.0% (34.6-41.5). In multivariate analysis, age under 10, no tobacco use, previous diagnosis of COVID-19, a history of COVID-19 related symptoms and contact with a COVID-19 case within the household, were independently associated with higher SARS-CoV-2 seroprevalence. More than one third of people living in Tunis obtained antibodies to SARS-CoV-2. Further studies are needed to monitor changes in these figures as Tunisian population is confronted to the subsequent epidemic waves and to guide the vaccine strategy.
Keywords: SARS-CoV-2; Tunisia; seroepidemiologic studies.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- World Health Organization Listings of WHO’s Response to COVID-19. [(accessed on 30 November 2021)]. Available online: https://www.who.int/news/item/29-06-2020-covidtimeline.
-
- World Health Organization Weekly Epidemiological Update on COVID-19—30 March 2021. [(accessed on 30 November 2021)]. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
-
- WHO WHO Coronavirus (COVID-19) Dashboard. 2021. [(accessed on 30 November 2021)]. Available online: https://covid19.who.int.
-
- National Observatory of New and Emerging Diseases COVID-19 en Tunisie: Point de Situation a la Date du 07 Juin 2020. [(accessed on 30 November 2021)]. Available online: https://www.onmne.tn/?p=10229.
-
- National Observatory of New and Emerging diseases Point de Situation sur L’épidémie D’infections au Nouveau Coronavirus « COVID-19 » à la Date du 17 Mars 2020. [(accessed on 22 December 2021)]. Available online: https://www.onmne.tn/?p=10363.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
